Скачать
Impact of ide-cel and future directions
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2021-05-10
Просмотров: 79
Описание: This year we saw the FDA approval of idecabtagene vicleucel (ide-cel; formerly bb2121) for the treatment of adult patients with relapsed or refractory multiple myeloma. In this video, Nikhil Munshi, MD, Dana-Farber Cancer Institute, Boston, MA, talks on the wider impact of this approval and where he believes ide-cel will move. Specifically discussed is the use of CAR-T in combination with other therapies, and the movement of CAR-T into earlier lines of treatment. This interview took place during the 2nd Immune Effector Cell Therapy in MM Workshop in Boston, MA.
Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
